Empyrean Capital Partners’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Empyrean Capital Partners’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-463,822	Closed	-$195K	–	195
2022 Q1	$195K	Hold	463,822	–	–	﹤0.01%	166
2021 Q4	$404K	Hold	463,822	–	–	0.01%	156
2021 Q3	$533K	Hold	463,822	–	–	0.01%	158
2021 Q2	$612K	Hold	463,822	–	–	0.01%	163
2021 Q1	$677K	Buy	+463,822	New	+$1.17M	0.02%	141

Other funds holding LUXAW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Empyrean Capital Partners's LUXAW Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q2 2022, closing a stake of 463,822 shares — an estimated $195K sold.

Empyrean Capital Partners first reported a position in LUXAW in Q1 2021 and held it in 5 quarters. The position peaked at $677K in Q1 2021. 30 funds tracked by Wall St. Rank hold LUXAW as of Q2 2022.

Empyrean Capital Partners reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q2 2022 after selling out during the quarter.
Empyrean Capital Partners sold 463,822 Lux Health Tech Acquisition Corp. Warrants shares in Q2 2022, an estimated $195K.
Empyrean Capital Partners first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 5 quarters.
Empyrean Capital Partners's Lux Health Tech Acquisition Corp. Warrants position peaked at $677K in Q1 2021.
30 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.